Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrolide addition to ceftriaxone for HIV-associated community-acquired pneumonia
RBR-8wtq2bCompleted
- Sponsor
- Instituto de Infectologia Emílio Ribas
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ceftriaxone, azithromycin and clarithromycin in community-acquired pneumonia (CAP) (2 arms), sponsored by Instituto de Infectologia Emílio Ribas. Started Sep 2012; status: completed.
02
Drugs
ceftriaxoneazithromycinclarithromycin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on RBR-8wtq2b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8wtq2b.